Product

Donafenib Tosilate

Aliases

Donafenib Tosilate Tablets

2 clinical trials

1 indication

Indication

Hepatocellular Carcinoma

Clinical trial

Dose Escalation Study Of Donafenib and Toripalimab Combined With TACE in Patients With Unresectable Hepatocellular Carcinoma

Status: Active (not recruiting), Estimated PCD: 2024-12-01

Clinical trial

A Study Evaluating the Efficacy and Safety of ZG005 in Combination With Donafenib Tosilate Tablets or Bevacizumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

Status: Not yet recruiting, Estimated PCD: 2026-01-01